Business Wire

PureTech Founded Entity Vor Biopharma Announces VOR33 Granted U.S. FDA Fast Track Designation for Acute Myeloid Leukemia

BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, is pleased to note that its Founded Entity, Vor ...
FierceBiotech

Vor's cancer cell therapy gets on FDA fast track ahead of 2022 data drop

The FDA has become the latest organization to validate the potential of Vor Biopharma’s approach to CRISPR-powered cell engineering, granting fast-track status to its lead asset shortly after Johnson ...
Business Insider

Vor Biopharma Says FDA Grants Fast Track Designation To VOR33 For Acute Myeloid Leukemia

(RTTNews) - Vor Biopharma (VOR), a clinical-stage cell and genome engineering company, announced that its VOR33 was granted Fast Track designation by the U.S. Food and Drug Administration. VOR33 is ...
Nasdaq

Vor Biopharma Says FDA Grants Fast Track Designation To VOR33 For Acute Myeloid Leukemia

(RTTNews) - Vor Biopharma (VOR), a clinical-stage cell and genome engineering company, announced that its VOR33 was granted Fast Track designation by the U.S. Food and Drug Administration. VOR33 is ...